|
| 2,5-DiMethyl Celecoxib Basic information |
| 2,5-DiMethyl Celecoxib Chemical Properties |
Melting point | >138°C (dec.) | Boiling point | 516.7±60.0 °C(Predicted) | density | 1.40±0.1 g/cm3(Predicted) | storage temp. | room temp | solubility | DMSO: soluble20mg/mL, clear | pka | 9.67±0.10(Predicted) | form | powder | color | white to beige |
Hazard Codes | T | Risk Statements | 25 | Safety Statements | 45 | RIDADR | UN 2811 6.1 / PGIII | WGK Germany | 3 |
| 2,5-DiMethyl Celecoxib Usage And Synthesis |
Uses | A non-cyclooxygenase-2 inhibitor analog of Celecoxib (C251000). The celecoxib analog, 2,5-di-Me celecoxib (DMC), lacks COX-2 inhibitory activity but exhibits cytotoxic properties comparable to the COX-2 inhibitor Celecoxib.
| Uses | 2,5-Dimethyl-celecoxib has been used
- To block the synthesis of prostaglandin E2 and to study effect of transforming growth factor-2 signaling towards cyclooxygenase-2 expression.
- In an in vitro study to analyze its pro-oxidative capacities in metastatic melanoma/ breast cancer cells.
- To study its interaction between silymarin on chemically induced osteoarthritis in rats.
| Biochem/physiol Actions | Celecoxib, and the inactive analog 2′,5′-dimethyl celecoxib both induce apoptosis in a many cancer cell lines by down-regulating the expression of survivin. This activiy is mediated via an AKT mediated pathway, and is unique to this class of cyclo-oxygenase inhibitors, as non-selective NSAIDs or other COX-2 specific inhibitors such as rofecoxib, do not effect survivin expression. Unlike celecoxib, 2′,5′-dimethyl celecoxib is devoid of any inhibitory activity against COX-2. | storage | Room temperature |
| 2,5-DiMethyl Celecoxib Preparation Products And Raw materials |
|